Nifedipine vs Verapamil
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Nifedipine (Procardia, Adalat) and verapamil (Calan, Verelan) are both calcium channel blockers (CCBs), but they belong to different subclasses with distinct clinical applications. Nifedipine is a dihydropyridine CCB that primarily relaxes blood vessels, while verapamil is a non-dihydropyridine CCB that affects both blood vessels and the heart's electrical conduction system.
This difference in mechanism means they are used for overlapping but distinct indications. Both treat hypertension, but verapamil also treats certain arrhythmias and is used differently in angina management.
Nifedipine vs Verapamil: Side-by-side comparison
| Category | Nifedipine | Verapamil |
|---|---|---|
| CCB Subclass | Dihydropyridine | Non-dihydropyridine |
| Brand Names | Procardia, Adalat | Calan, Verelan |
| Primary Effect | Vasodilation | Vasodilation + heart rate control |
| Arrhythmia Use | No | Yes (SVT, atrial fibrillation) |
| Safe with Beta-Blockers | Yes | Generally no |
| Common Side Effect | Ankle swelling, flushing | Constipation, bradycardia |
| Edema Risk | High (10-30%) | Lower |
Efficacy: How well does each drug work?
Both nifedipine and verapamil effectively lower blood pressure. Nifedipine is a potent vasodilator and typically reduces systolic blood pressure by 10-20 mmHg. Extended-release nifedipine is widely used as a first- or second-line antihypertensive.
Verapamil lowers blood pressure through both vasodilation and reduction of heart rate and cardiac output. It is particularly effective in patients who also have supraventricular tachycardia (SVT) or atrial fibrillation, as it slows conduction through the AV node — a property nifedipine does not have.
For angina, both drugs reduce oxygen demand. Nifedipine works primarily by reducing afterload (vessel resistance), while verapamil reduces both heart rate and afterload. Verapamil may be preferred for patients with angina accompanied by fast heart rates.
Side effects comparison
Nifedipine's most common side effects are related to vasodilation: headache, flushing, dizziness, and peripheral edema (ankle swelling). Edema occurs in up to 10-30% of patients and can be significant enough to require discontinuation.
Verapamil causes less peripheral edema but more commonly causes constipation (up to 25% of patients), which can be severe. It can also cause bradycardia (slow heart rate) and, rarely, heart block — these cardiac effects are not seen with nifedipine.
Important safety difference: verapamil should not be combined with beta-blockers in most cases due to the risk of severe bradycardia and heart block. Nifedipine can be safely combined with beta-blockers and this combination is commonly used for angina.
Cost comparison
Both nifedipine and verapamil are available as affordable generics. Generic extended-release nifedipine costs $10-$30 per month, and generic verapamil costs $10-$25 per month. Both are widely covered by insurance plans.
Convenience and dosing
Extended-release formulations of both drugs are taken once daily, making them equally convenient for blood pressure management. Immediate-release nifedipine is taken 3 times daily (though it is now rarely used for hypertension due to safety concerns about rapid blood pressure drops).
Verapamil requires closer cardiac monitoring, especially when started or when dose is changed, due to its effects on heart rate and conduction. Nifedipine does not require cardiac monitoring.
Which is right for you?
If your primary concern is blood pressure control, both drugs are effective. Nifedipine may be preferred if you are also taking a beta-blocker, since this combination is safe and commonly used. If you are prone to constipation, nifedipine is the better choice.
Verapamil may be preferred if you have supraventricular tachycardia or atrial fibrillation, as it treats both the arrhythmia and high blood pressure. If you experience significant ankle swelling on nifedipine, verapamil may cause less edema.
Your doctor will consider your heart rhythm, other medications, and side effect concerns when choosing between these calcium channel blockers.
Frequently asked questions
References
- [Observational] Nifedipine Extended-Release FDA Label https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019684s027lbl.pdf Accessed 2026-03-01.
- [Observational] Verapamil FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018817s028lbl.pdf Accessed 2026-03-01.
- [Observational] Calcium Channel Blockers - StatPearls https://www.ncbi.nlm.nih.gov/books/NBK482473/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: